Enable your JavaScript to use Numstock


Numstock » ADMP

ADMP Stock Analysis

The latest metrics for Adamis Pharmaceuticals Corporation

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -1.04
Price / Book Value Ratio < 1.5 1.33
Price / Sales Ratio < 2.0 2.08
PEG Ratio < 1.0 0.0
EV / EBITDA Ratio < 8.0 -1.34
Price / FCF Ratio Last Year < 15.0 -0.79
Price / FCF Ratio Last Quarter < 15.0 -6.59
Price / TBV Ratio Last Year < 0.7 1.31
Price / TBV Ratio Last Quarter < 0.7 2.31
Price / NCAV Ratio Last Year < 0.7 2.4
Price / NCAV Ratio Last Quarter < 0.7 8.43

Efficiency

Metric Target Value
ROE Last Year > 25.0% -90.46
ROE Last Quarter > 25.0% -18.89
ROA Last Year > 15.0% -66.84
ROA Last Quarter > 15.0% -13.25
ROTA Last Year > 20.0% -74.66
ROTA Last Quarter > 20.0% -13.26
ROIC Last Year > 20.0% -113.7
ROIC Last Quarter > 20.0% -19.65
ROCE Last Year > 20.0% -84.29
ROCE Last Quarter > 20.0% -16.97
Inventory Turnover Last Year > 4.0 2.99
Inventory Turnover Last Quarter > 4.0 1.71
Pre-tax Margin Last Year > 20.0% -327.3
Pre-tax Margin Last Quarter > 20.0% -150.1
Accounts Payable Turnover Last Year > 3.0 2.35
Accounts Payable Turnover Last Quarter > 3.0 1.28
Accounts Receivable Turnover Last Year > 5.0 8.48
Accounts Receivable Turnover Last Quarter > 5.0 3.72

Health

Metric Target Value
Current Ratio Last Year > 1.5 2.23
Current Ratio Last Quarter > 1.5 1.58
Quick Ratio Last Year > 1.5 1.95
Quick Ratio Last Quarter > 1.5 1.37
Flow Ratio Last Year < 1.25 0.73
Flow Ratio Last Quarter < 1.25 0.66
Debt / Equity Ratio Last Year < 0.5 0.0
Debt / Equity Ratio Last Quarter < 0.5 0.0
Debt / EBITDA Ratio Last Year < 4.0 0.0
Debt / EBITDA Ratio Last Quarter < 4.0 0.0
Debt / NCAV Ratio Last Year < 2.0 0.0
Debt / NCAV Ratio Last Quarter < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.0
Interest Coverage Ratio Ratio Last Year > 8.0 250.1
Interest Coverage Ratio Last Quarter > 8.0 319.5
FCF / Sales Ratio Last Year > 8.0% -239.9
FCF / Sales Ratio Last Quarter > 8.0% -78.24

Growth

Metric Target Value
Earnings Yield > 12% -95.77
Ebit Yield Last Year > 12% -86
Ebit Yield Last Quarter > 12% -13
FCF Yield Last Year > 10% -67.68
FCF Yield Last Quarter > 10% -8.64
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 1.01
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.09

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -5
Altman Z-score Last Quarter ≥ 3.5 -4.3